Executive Summary
Asian benchmark FOB China Acetonitrile prices witnessed an upward momentum this week, rising by 0.88% to $916/MT. The increase is primarily driven by stronger demand from South Asia, particularly from pharmaceutical manufacturers. Demand is gaining traction as GLP-1 API producers ramp up production of peptide-based therapies targeting the Type 2 diabetes segment, supporting higher acetonitrile consumption.
Market Pricing Dashboard
| Region / Commodity | Spot Price | Last Week | % Change |
|---|---|---|---|
| FOB China Acetonitrile ($/MT) | $916 | $908 | +0.88% |
| CIF India Acetonitrile (+ADD) | $1,261 | $1,253 | +0.64% |
| India (Domestic) Acetonitrile (Rs/MT) | ₹1,60,000 | ₹1,40,000 | +14.29% |
| FOB China Acetic Acid ($/MT) | $342 | $339 | +0.88% |
| CFR China Methanol ($/MT) | $261 | $264 | -1.14% |
India Market: Structural Shift & ADD Impact
India’s annual acetonitrile demand is estimated at 30,000 MT for 2025–26 and is projected to surge by nearly 29% to approximately 38,700 MT in 2026–27. Following the implementation of Anti-Dumping Duty (ADD) in June 2025, domestic manufacturers have significantly ramped up operating rates from 30% to nearly 60% utilization.
| Country of Origin | Anti-Dumping Duty (ADD) $/MT |
|---|---|
| China (Selected Producers) | $202 - $292 |
| China (Others) | $481 |
| Russia | $292 |
| Taiwan | $233 |
Indian Capacity: Path to Self-Sufficiency
With an installed capacity of 53.50 ktpa, current production levels (at 60% run rates) are reaching 32 kt, aligning closely with domestic demand of 35 kt.
| Manufacturer | Location | Capacity (MT/Yr) |
|---|---|---|
| Alkyl Amines Ltd | Dahej | 21,000 |
| Alkyl Amines Ltd | Kurkumbh | 12,000 |
| Jindal Speciality Chemicals | Kheda | 10,000 |
| Balaji Amines Ltd | Solapur | 9,000 |
| Deepak Novo Tech Ltd | N/A | 1,500 |
Production Economics: Direct Synthesis Margin
Unlike the global Sohio by-product route, Indian producers synthesize ACN directly from Acetic Acid and Ammonia, making them sensitive to acetyls pricing.
Estimated Producer Margin (India)
- Acetic Acid (1.60 MT @ $379/MT): $606
- Ammonia (0.51 MT @ $400/MT): $204
- Caustic Soda Lye (0.30 MT @ $384/MT): $115
- Conversion & Utility Costs: $150
- Total Production Cost: ~$1,075/MT
- Current Spot Price (Ex-Works): ~$1,261/MT
- Estimated Margin: +$186/MT
The Semaglutide Catalyst
A key incremental demand driver is the expanding production of Semaglutide (Ozempic/Wegovy). As generic API manufacturers in India prepare for patent expiries, solvent intensity is rising. Acetonitrile is essential for:
- Peptide coupling and downstream processing.
- Extensive High-Performance Liquid Chromatography (HPLC) purification.
- Contract manufacturing (CDMO/CRAMS) mandates for regulated markets.
Techno-Commercial Route Comparison
| Feature | Sohio By-product (Global) | Direct Synthesis (India) |
|---|---|---|
| Production Nature | Incidental (2-4% yield) | Purpose-built (Primary) |
| Energy Intensity | Low (Shared burden) | High (Vapor-phase reaction) |
| Supply Reliability | Cyclical (Acrylonitrile linked) | Stable (Acetyls linked) |
| Carbon Footprint | Lower | Moderate-High |
Market Outlook
The short-term outlook is firm to bullish. Key drivers include peptide and GLP-1 API scale-ups, preparation for the semaglutide generic pipeline, and improved capacity utilization in India post-ADD. For FY27, demand is expected to shift from cyclical to structural as India solidifies its position as a peptide API hub.